Dongjun Peng et al. revealed that MDSC could enhance CSC stemness and inhibit T-cells activation via the STAT3-NOTCH signal pathway in breast cancer; they found its potential to inhibit CSCs and immune escape via targeting STAT3-NOTCH crosstalk [190]. Here, STAT3 is linked to breast cancer.